Thompson Siegel & Walmsley’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
ICP
MRCP
BBCM
Thompson Siegel & Walmsley's NGVT Position: Q2 2022 in Review
Thompson Siegel & Walmsley sold out of Ingevity (NGVT) in Q2 2022, closing a stake of 734 shares — an estimated $47K sold.
Thompson Siegel & Walmsley first reported a position in NGVT in Q2 2016 and held it in 24 quarters. The position peaked at $2.49M in Q2 2020. 264 funds tracked by Wall St. Rank hold NGVT as of Q2 2022.
- Thompson Siegel & Walmsley reported no remaining Ingevity position as of Q2 2022 after selling out during the quarter.
- Thompson Siegel & Walmsley sold 734 Ingevity shares in Q2 2022, an estimated $47K.
- Thompson Siegel & Walmsley first reported a position in Ingevity in Q2 2016 and held it in 24 quarters.
- Thompson Siegel & Walmsley's Ingevity position peaked at $2.49M in Q2 2020.
- 264 funds tracked by Wall St. Rank held Ingevity as of Q2 2022.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2022, filed 22 Jul 2022.